In a case report published in Blood Research, researchers Neha Seth and Aishwarya Ravindran describe a significant diagnostic challenge involving acute myeloid leukemia with monocytic differentiation and a TP53 mutation. Following induction chemotherapy, the patient’s disease exhibited a striking histiocytoid morphologic transformation, altering the typical appearance of the post-treatment leukemic blast cells.
Detailed examination showed that the post-treatment myeloid-lineage blasts had undergone substantial structural changes, creating marked morphologic overlap with mature malignant histiocytic neoplasms. The investigators noted that this deceptive resemblance was particularly evident when compared against the histiocytic sarcoma subtype, leading to notable diagnostic complexity.
This pronounced morphological mimicry represented a critical diagnostic pitfall during post-treatment disease evaluation. Because the transformed leukemic blasts closely imitated mature histiocytic cells, the observed cellular changes raised the challenging question of distinguishing persistent leukemia from a divergent histiocytic malignancy.
To address this diagnostic challenge, the investigators assessed specific protein marker expressions within the post-treatment blast population. Their laboratory evaluation identified retained myeloperoxidase expression together with a complete absence of cyclin D1 expression in the transformed cells.
These immunophenotypic findings provided essential evidence to clarify the patient’s diagnosis. Retained myeloperoxidase expression, alongside the lack of cyclin D1, supported a diagnosis of persistent acute myeloid leukemia rather than divergent histiocytic differentiation, resolving the deceptive morphologic overlap.
Subject of Research: Histiocytoid morphologic transformation in TP53-mutated acute myeloid leukemia
Article Title: Myeloid-lineage blasts with histiocytoid differentiation in TP53 mutated acute myeloid leukemia: a deceptive morphologic overlap with mature malignant histiocytic neoplasms
Article References: Seth, N., & Ravindran, A. (2026). Myeloid-lineage blasts with histiocytoid differentiation in TP53 mutated acute myeloid leukemia: a deceptive morphologic overlap with mature malignant histiocytic neoplasms. Blood Research, 61(1), Article 40. https://doi.org/10.1007/s44313-026-00156-z
Image Credits: AI Generated
DOI: 10.1007/s44313-026-00156-z
Keywords: acute myeloid leukemia, TP53 mutation, histiocytoid differentiation, histiocytic neoplasms, histiocytic sarcoma, chemotherapy, myeloperoxidase, cyclin D1, Myeloid-lineage, blasts, histiocytoid, differentiation
News Source: Nathaniel Bowman. (November 8, 2026). Transformed Blasts in TP53-Mutated Leukemia Mimic Malignant Histiocytic Neoplasms. Scienmag.



